Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report)’s share price shot up 1.7% during trading on Tuesday . The stock traded as high as $2.44 and last traded at $2.36. 106,888 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 261,100 shares. The stock had previously closed at $2.32.
Aadi Bioscience Trading Up 1.7%
The stock’s 50 day moving average price is $2.27 and its 200 day moving average price is $2.00. The company has a market cap of $58.28 million, a price-to-earnings ratio of -1.04 and a beta of 0.68.
About Aadi Bioscience
Aadi Bioscience, Inc, a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.
Further Reading
- Five stocks we like better than Aadi Bioscience
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
- How to Invest in the Best Canadian Stocks
- RTX Surges to Record Highs as Defense Orders Explode
- What Makes a Stock a Good Dividend Stock?
- Smart Money Is Buying Auto Suppliers, Not Car Brands
Receive News & Ratings for Aadi Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aadi Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
-ltd-logo-1200x675.jpg?v=20230317161434&h=54&w=95&zc=2){kind=logo}
